From StockTwits: 2025-01-05 23:56:06

Shares of beer and wine maker Constellation Brands dropped 0.29% amid a broader decline in beverage company stocks after the U.S. Surgeon General linked alcohol consumption to cancer. Constellation is set to report third-quarter earnings this week, with Wall Street expecting $3.33 EPS on $2.54 billion in revenue. In the previous quarter, Constellation beat EPS estimates by 5.78%, with revenues at $2.92 billion. UBS lowered the price target to $265, but maintained a ‘Buy’ rating. Other beverage stocks like Anheuser-Busch and Diageo also saw declines. Constellation stock is up 0.25% year-to-date.



Read more at StockTwits: Constellation Brands Stock In Focus On Analyst Revision: Retail’s Neutral